Miracle Mile Advisors »

Akero Therapeutics shares owned by Miracle Mile Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Miracle Mile Advisors from 13F filings

Historical chart of Miracle Mile Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Miracle Mile Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Miracle Mile Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $238k 4.7k 50.58

More positions owned by Miracle Mile Advisors

Schwab Strategic Tr Intl Eqty Etf (SCHF)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Series Trust Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Mbs Etf (MBB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Ishares Tr A Rate Cp Bd Etf (QLTA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Amazon (AMZN)

View all positions for Miracle Mile Advisors

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
Rtw Investments
Wellington Management Company
Deep Track Capital
venBio Select Advisor
State Street Corporation
Bellevue Group
Point72 Asset Management
Alkeon Capital Management
Geode Capital Management
Alliancebernstein
Marshall Wace
Logos Global Management

View all funds holding Akero Therapeutics